D. Ferry
Impact in
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
- Biochemistry top 2%
- Phytochemicals and Antioxidant Activities
Papers in
- Oncology 40
- Colorectal Cancer Treatments and Studies 20
- Cancer Treatment and Pharmacology 7
- Drug Transport and Resistance Mechanisms 7
-
- Gastric Cancer Management and Outcomes 17
- Lung Cancer Treatments and Mutations 13
- Co-authors
- Hartmut Glossmann (14 shared papers)A. Göll (11 shared papers)D. Fyfe (3 shared papers)Heidi Traunecker (2 shared papers)David A. Anderson (2 shared papers)J Baker (1 shared paper)Adam J. de Smith (1 shared paper)Rachel Kerr (2 shared papers)
- Journals
- Annals of Oncology (20 papers)Journal of Clinical Oncology (10 papers)European Journal of Cancer (7 papers)British Journal of Cancer (7 papers)Thorax (5 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
D. Ferry
84 papers receiving 4.2k citations
D. Ferry's Hit Papers
Peers
Comparison fields: 5 of 131
- Oncology 1.3k
- Biochemistry 251
- Pulmonary and Respiratory Medicine 823
- Biomaterials 361
- Internal Medicine 80
Countries citing papers authored by D. Ferry
This map shows the geographic impact of D. Ferry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Ferry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Ferry more than expected).
Fields of papers citing papers by D. Ferry
This network shows the impact of papers produced by D. Ferry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Ferry. The network helps show where D. Ferry may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Ferry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Hit paper breakdown → | 1996 | 569 |
| 2 | 1999 | 363 | |
| 3 | 2004 | 332 | |
| 4 | 2016 | 320 | |
| 5 | 1996 | 192 | |
| 6 | 2017 | 153 | |
| 7 | 2001 | 141 | |
| 8 | [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes. | 1981 | 123 |
| 9 | 1984 | 112 | |
| 10 | 2016 | 104 | |
| 11 | 1998 | 99 | |
| 12 | 1994 | 96 | |
| 13 | 1997 | 95 | |
| 14 | 2001 | 91 | |
| 15 | 2017 | 91 | |
| 16 | 1983 | 91 | |
| 17 | 1993 | 83 | |
| 18 | 2017 | 78 | |
| 19 | 2009 | 65 | |
| 20 | 2013 | 63 |
About D. Ferry
D. Ferry is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Cellular and Molecular Neuroscience, having authored 88 papers that have together received 4.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (20 papers), Gastric Cancer Management and Outcomes (17 papers), Ion channel regulation and function (13 papers), Lung Cancer Treatments and Mutations (13 papers), Esophageal Cancer Research and Treatment (10 papers), Neuroscience and Neuropharmacology Research (7 papers), Cancer Treatment and Pharmacology (7 papers) and Drug Transport and Resistance Mechanisms (7 papers). The work is most often cited by research in Oncology (1.3k citations), Biochemistry (251 citations), Pulmonary and Respiratory Medicine (823 citations), Biomaterials (361 citations) and Internal Medicine (80 citations). D. Ferry has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Hartmut Glossmann, A. Göll, D. Fyfe, Heidi Traunecker, David A. Anderson, J Baker, Adam J. de Smith, Rachel Kerr, David J. Kerr and David Kerr. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, European Journal of Cancer, British Journal of Cancer and Thorax.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.